UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

A comparison of venlafaxine, trazodone, and placebo in major depression

Journal of clinical psychopharmacology, 1994-04, Vol.14 (2), p.99-106

1994

Volltextzugriff (PDF)

ICI 204,636, an atypical antipsychotic : Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia

Journal of clinical psychopharmacology, 1996-04, Vol.16 (2), p.158-169

1996

Volltextzugriff (PDF)

The role of cognition in the risk-benefit and safety analysis of antipsychotic medication

Acta psychiatrica Scandinavica, 1996-01, Vol.94 (s389), p.5-11

Borison, R.L.

1996

Volltextzugriff (PDF)

Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics

Journal of clinical psychopharmacology, 1995-02, Vol.15 (1 Suppl 1), p.24S-29S

Borison, R L

1995

Volltextzugriff (PDF)

Recent Advances in the Pharmacotherapy of Schizophrenia

Harvard review of psychiatry, 1997, Vol.4 (5), p.255-271

Borison, Richard L.

1997

Volltextzugriff (PDF)

Association of transient SIADH with sertraline

The American journal of psychiatry, 1994-05, Vol.151 (5), p.779b-780

1994

Volltextzugriff (PDF)

Paroxetine Treatment of Anger Associated with Depression

The journal of nervous and mental disease, 1995-10, Vol.183 (10), p.666-666

1995

Volltextzugriff (PDF)

Changing antipsychotic medication: guidelines on the transition to treatment with Risperidone

Clinical therapeutics, 1996-07, Vol.18 (4), p.592-607

Borison, Richard L

1996

Volltextzugriff (PDF)

Unexpected dystonia while changing from clozapine to risperidone

Journal of clinical psychopharmacology, 1995-06, Vol.15 (3), p.225-226

1995

Volltextzugriff (PDF)

The oral dose-effect relationship for fluvoxamine: a fixed-dose comparison against placebo in depressed outpatients

Annals of clinical psychiatry, 1996-09, Vol.8 (3), p.139

1996

Volltextzugriff (PDF)

Phenomenology and neurobiology of cocaine withdrawal: Are they related?

Progress in neuro-psychopharmacology & biological psychiatry, 1995-10, Vol.19 (6), p.1021-1034

1995

Volltextzugriff (PDF)

The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders

JAMA : the journal of the American Medical Association, 1991-10, Vol.266 (13), p.1793

1991

Volltextzugriff (PDF)

Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo

Biological psychiatry (1969), 1997-08, Vol.42 (4), p.233-246

1997

Volltextzugriff (PDF)

A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study

European archives of psychiatry and clinical neuroscience, 1995-03, Vol.245 (1), p.45-49

1995

Volltextzugriff (PDF)

Pharmacology of antipsychotic drugs

The journal of clinical psychiatry, 1985-01, Vol.46 (4 Pt 2), p.25

Borison, R L

1985

Volltextzugriff (PDF)

Olanzapine versus placebo and haloperidol : Acute phase results of the North American double-blind olanzapine trial

Neuropsychopharmacology (New York, N.Y.), 1996-02, Vol.14 (2), p.111-123

1996

Volltextzugriff (PDF)

Open-loop comparison of carotid sinus reflex respiratory and circulatory effects in cats

The Journal of physiology, 1983-03, Vol.336 (1), p.113-129

1983

Volltextzugriff (PDF)

Amantadine-induced psychosis in a geriatric patient with renal disease

The American journal of psychiatry, 1979-01, Vol.136 (1), p.111-112

Borison, R L

1979

Volltextzugriff (PDF)

Ventricle-to-Brain Ratio and Symptoms at the Onset of First-Break Schizophrenia

Schizophrenia bulletin, 1992, Vol.18 (3), p.427-435

1992

Volltextzugriff (PDF)

Amantadine in the management of extrapyramidal side effects

Clinical neuropharmacology, 1983, Vol.6 Suppl 1, p.S57-63

Borison, R L

1983

Volltextzugriff (PDF)

Modulation of dopamine receptor sensitivity by estrogen

Biological psychiatry (1969), 1980-06, Vol.15 (3), p.389-396

1980

Volltextzugriff (PDF)

Risperidone: clinical safety and efficacy in schizophrenia

Psychopharmacology bulletin, 1992, Vol.28 (2), p.213

1992

Volltextzugriff (PDF)

Regional selectivity of neuroleptic drugs: An argument for site specificity

Brain research bulletin, 1983-01, Vol.11 (2), p.215-218

1983

Volltextzugriff (PDF)

Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing

Clinical therapeutics, 1996-07, Vol.18 (4), p.592

Borison, R L

1996

Volltextzugriff (PDF)

Treatment approaches in Gilles de la Tourette syndrome

Brain research bulletin, 1983-08, Vol.11 (2), p.205-208

1983

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(139)
Buchkapitel
(1)

Sprache

Englisch
(140)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(87)
Humans
(66)
Animals
(53)
Male
(51)
Pharmacology & Pharmacy
(43)
Psychiatry
(35)
Female
(33)
Adult
(29)
Neurosciences & Neurology
(29)
Middle Aged
(25)
Neurosciences
(24)
Biological And Medical Sciences
(23)
Cats
(22)
Medical Sciences
(22)
Rats
(19)
Schizophrenia - Drug Therapy
(18)
Neuropharmacology
(15)
Pharmacology. Drug Treatments
(14)
Psychology. Psychoanalysis. Psychiatry
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A comparison of venlafaxine, trazodone, and placebo in major depression

ICI 204,636, an atypical antipsychotic : Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia

The role of cognition in the risk-benefit and safety analysis of antipsychotic medication

Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics

Recent Advances in the Pharmacotherapy of Schizophrenia

Association of transient SIADH with sertraline

Paroxetine Treatment of Anger Associated with Depression

Changing antipsychotic medication: guidelines on the transition to treatment with Risperidone

Unexpected dystonia while changing from clozapine to risperidone

The oral dose-effect relationship for fluvoxamine: a fixed-dose comparison against placebo in depressed outpatients

Phenomenology and neurobiology of cocaine withdrawal: Are they related?

The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders

Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo

A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study

Pharmacology of antipsychotic drugs

Olanzapine versus placebo and haloperidol : Acute phase results of the North American double-blind olanzapine trial

Open-loop comparison of carotid sinus reflex respiratory and circulatory effects in cats

Amantadine-induced psychosis in a geriatric patient with renal disease

Ventricle-to-Brain Ratio and Symptoms at the Onset of First-Break Schizophrenia

Amantadine in the management of extrapyramidal side effects

Modulation of dopamine receptor sensitivity by estrogen

Risperidone: clinical safety and efficacy in schizophrenia

Regional selectivity of neuroleptic drugs: An argument for site specificity

Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing

Treatment approaches in Gilles de la Tourette syndrome

Suchergebnisse filtern